I was surprised that the gender of the subjects is not stated. Males and females have different serum ferritin levels and thus they should be considered separately.
GENERAL COMMENTS
I was surprised that the gender of the subjects is not stated. Males and females have different serum ferritin levels and thus they should be considered separately.
The discussion is rather long and little informative. It should explain the meaning of the results, in particular the clinical significance of the indicated additive interaction between serum ferritin and BMI, and the RERI.
REVIEWER

Alexandre Stewart
University of Ottawa Heart Institute REVIEW RETURNED 25-Sep-2013
GENERAL COMMENTS
The manuscript by Jia et al. titled "Joint effects of serum ferritin and body mass index on the risk of coronary artery disease" describes an interaction between the risk of elevated serum ferritin and increased body mass index on the risk of coronary artery disease in a retrospective angiographic study.
The authors hypothesized that "Since both serum ferritin and BMI have been shown to be independently associated with CAD risk, the hypothesis is that there should be an interaction between serum ferritin and BMI on CAD risk." Reading their manuscript, one is given the impression that the link between obesity and ferritin levels has not been firmly established. However, the fact that obesity elevates serum ferritin levels has been reported by several groups (reviewed in Cheng HL, Bryant C, Cook R, O'Connor H, Rooney K, Steinbeck K. Obes Rev. 2012 Feb;13(2):150-61). 2012;32:2525-2530) . Given the small sample size reported in this study, it would be important to acknowledge the larger study.
The authors should provide the "Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998;438:159-60" reference for 8-iso-PGF2α as a marker of oxidative stress.
Despite the limitations of this study, the manuscript by Jia et al. does present a novel previously unreported interaction between elevated serum ferritin and elevated BMI for the risk of CAD and as such, this study merits reporting.
Minor point, the in hospital sample might introduce "selection bias" not "selected bias" as written on page 11, in the Discussion.
VERSION 1 -AUTHOR RESPONSE
1. I was surprised that the gender of the subjects is not stated. Males and females have different serum ferritin levels and thus they should be considered separately. Reply: Yes, many thanks for your careful review and suggestions. We reanalyzed our data in strata of gender, please see the section of Results and Tables (Table 1 -3) in the revision. 2. The discussion is rather long and little informative. It should explain the meaning of the results, in particular the clinical significance of the indicated additive interaction between serum ferritin and BMI, and the RERI. Reply: Yes, thank you for your suggestion. We further discussed the clinical significance of the indicated additive interaction between serum ferritin and BMI and the implication of RERI in detail in the revised manuscript.
Reviewer: Alexandre Stewart University of Ottawa Heart Institute 1. The authors hypothesized that "Since both serum ferritin and BMI have been shown to be independently associated with CAD risk, the hypothesis is that there should be an interaction between serum ferritin and BMI on CAD risk." Reading their manuscript, one is given the impression that the link between obesity and ferritin levels has not been firmly established. However, the fact that obesity elevates serum ferritin levels has been reported by several groups (reviewed in Cheng HL, Bryant C, Cook R, O'Connor H, Rooney K, Steinbeck K. Obes Rev. 2012 Feb;13(2):150-61). Reply: Yes, many thanks for your careful review. Both serum ferritin and obesity are independently associated with increased risk of CAD, and in this study we focused on the interaction between serum ferritin and BMI on CAD risk. The existed additive interaction between serum ferritin and BMI on the risk of CAD indicated in this paper confirmed the link between obesity and ferritin levels. We also cited the above paper (Cheng HL, Bryant C, Cook R, O'Connor H, Rooney K, Steinbeck K. Obes Rev. 2012 Feb;13(2):150-61) as a reference in the revision to further acknowledge our results.
2. The effect of elevated ferritin on increasing the likelihood of angiographic CAD has been reported in a large Korean population sample (Sung KC, Kang SM, Cho EJ, Park JB, Wild SH, Byrne CD. Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men. Arterioscler Thromb Vasc Biol. 2012; 32:2525 -2530 . Given the small sample size reported in this study, it would be important to acknowledge the larger study. Reply: Many thanks for so many valuable references. We cited and acknowledged this important large study in our revised manuscript.
3. The authors should provide the "Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998;438:159-60" reference for 8-iso-PGF2α as a marker of oxidative stress. Reply: Yes, thanks for your suggestion. We cited this paper as a reference in our revision. 4. Despite the limitations of this study, the manuscript by Jia et al. does present a novel previously unreported interaction between elevated serum ferritin and elevated BMI for the risk of CAD and as such, this study merits reporting. Reply: Thank you very much. 5. Minor point, the in hospital sample might introduce "selection bias" not "selected bias" as written on page 11, in the Discussion. Reply: Thank you for your suggestion. We used "selection bias " instead of "selected bias " in our revised manuscript.
